Matthew J.
Bobby

Mr. Bobby’s clients have included ADT, AerCap, Afterpay, AmerisourceBergen, Aras, AveXis, BDT, British American Tobacco, Canadian National Railway, Centrica, Crown Castle, CyrusOne, DiaSorin, GreenSky, Hasbro, Honeywell, Illumina, Johnson & Johnson, Just Eat Takeaway.com, Kenvue, Light & Wonder, Lindsay Goldberg, Martin Marietta, National Grid, Northrop Grumman, Novartis, Olin, Owl Rock, Peugeot, RWE, SMBC Aviation Capital, Starwood Hotels, Thermo Fisher Scientific, Time Warner, US Foods, Viacom, Viatris and WestRock.

Mr. Bobby’s notable matters include representing:

• Lindsay Goldberg and its portfolio companies in connection with multiple transactions, including the acquisition of The Kleinfelder Group, Summit Interconnect in its acquisition of Royal Circuit Solutions and the sale of Pixelle to H.I.G. Capital;
• ADT in the pending $1.6 billion sale of its commercial business to GTCR;
• Hasbro in its $4 billion acquisition of Entertainment One (eOne), the pending sale of its eOne film and TV business to Lionsgate and the sale of eOne Music to Blackstone;
• Light & Wonder in the $6.05 billion sale of SG Lottery to Brookfield and $1.2 billion sale of OpenBet to Endeavor, its pending acquisition of the remaining stake in SciPlay, the $925.5 million sale of a 34.9% stake to institutional investors and its $363.5 million carve-out IPO of SciPlay;
• AngloGold Ashanti in its pending corporate restructuring and change to domicile and primary listing location;
• Owl Rock in Fifth Season Investments’ $220 million acquisition of Fifth Season Financial and the life insurance investment assets of Chapford Capital II and Chapford Diversified Strategies Fund;
• Johnson & Johnson in numerous matters, including the IPO and separation of Kenvue, its $16.6 billion acquisition of Abiomed, its $6.5 billion acquisition of Momenta, its $3.4 billion acquisition of Auris Health, the $2.8 billion sale of its Advanced Sterilization Products business to Fortive, the $2.1 billion sale of its LifeScan business to Platinum Equity, the $1.045 billion sale of its Codman Neurosurgery business to Integra and its $30 billion acquisition of Actelion;
• BDT and its affiliates in connection with multiple transactions, including BDT’s combination with MSD Partners and the take‑private acquisition of Weber, valuing Weber at $3.7 billion;
• RWE in its $6.8 billion acquisition of the Con Edison Clean Energy Businesses; 
• Martin Marietta in the proposed sale of its California cement plant and related terminals, the sale of certain West Coast cement and concrete operations to CalPortland and its $2.3 billion acquisition of Lehigh West Region;
• SMBC Aviation Capital in its $6.7 billion acquisition of Goshawk Aviation;
• CyrusOne in its $15 billion acquisition by KKR and Global Infrastructure Partners;
• GreenSky in its $2.24 billion acquisition by Goldman Sachs;
• Afterpay in its $29 billion acquisition by Block;
• Canadian National Railway in its proposed $33.6 billion combination with Kansas City Southern;
• Thermo Fisher Scientific in its $20.9 billion acquisition of PPD;
• National Grid in its £7.8 billion acquisition of Western Power Distribution and the $3.8 billion sale of Narragansett Electric;
• AerCap in its $30 billion acquisition of GE Capital Aviation Services;
• AmerisourceBergen in its $6.5 billion acquisition of Walgreens’ Alliance Healthcare businesses;

• Time Warner in its $109 billion sale to AT&T;

• Northrop Grumman in the $3.4 billion sale of its federal IT and mission support business to Veritas Capital;

• Illumina in its $8 billion acquisition of GRAIL;

• Centrica in its $3.625 billion sale of Direct Energy to NRG Energy;

• Just Eat Takeaway.com in its $7.3 billion acquisition of Grubhub;

• Novartis in its $29.8 billion spin‑off of Alcon;

• US Foods in its $500 million convertible preferred equity investment from KKR and its $970 million acquisition of Smart Foodservice;

• Olin in its $5 billion tax‑efficient Reverse Morris Trust merger with the chlorine value chain business of Dow Chemical;

• Peugeot in its $50 billion merger with Fiat Chrysler to form Stellantis;

• Viacom’s transaction committee in the $30 billion merger with CBS;

• WestRock in its $4.9 billion acquisition of KapStone;

• Starwood Hotels in its $13.3 billion sale to Marriott;

• British American Tobacco in its $97 billion acquisition of Reynolds American;

• AveXis in its $8.7 billion acquisition by Novartis;

• Crown Castle in several transactions, including its $7.1 billion acquisition of Lightower; and

• Mylan in its $9.9 billion acquisition of Meda, its proposal to acquire Perrigo in a transaction valued at approximately $35 billion and its $750 million acquisition, through its Indian subsidiary Mylan Laboratories, of certain female healthcare businesses from Famy Care.

Mr. Bobby received Euromoney Legal Media Group’s 2022 Americas Rising Star Award for “Best in Labor & Employment.” He is a frequent author and speaker on executive compensation and employee benefits topics and recently spoke on a panel at the American Bar Association’s 2023 Business Law Section Hybrid Spring Meeting.

Mr. Bobby was born in Pittsburgh, Pennsylvania. He received a B.A. summa cum laude in mathematics and physics and an M.A. in mathematics from the University of Pennsylvania in 2009, where he was elected to Phi Beta Kappa, and a J.D. magna cum laude from Harvard Law School in 2012, where he was an Executive Editor of the National Security Journal and the International Law Journal. Following his graduation, Mr. Bobby served as a law clerk to Hon. Joseph Jerome Farris of the U.S. Court of Appeals for the Ninth Circuit.

Mr. Bobby joined Cravath in 2013 and was elected a partner in 2020.